Expression of Bruton´s tyrosine kinase in different type of brain lesions of multiple sclerosis patients and during experimental demyelination

BACKGROUND: Inhibition of Bruton’s tyrosine kinase (BTK) is an emerging multiple sclerosis (MS) therapy. BTK inhibitors (BTKi) cross the blood-brain barrier and modulate B cells and microglia, major cellular players in active and chronic active lesions. OBJECTIVE: To assess potential lesional and ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkjaer, Maria L., Waede, Mie R., Kingo, Christina, Damsbo, Karina, Illes, Zsolt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679451/
https://www.ncbi.nlm.nih.gov/pubmed/38022591
http://dx.doi.org/10.3389/fimmu.2023.1264128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679451/
https://www.ncbi.nlm.nih.gov/pubmed/38022591
http://dx.doi.org/10.3389/fimmu.2023.1264128

Ejemplares similares